Scientists dive deep into immune secrets of ARDS to unlock future treatments
NCT ID NCT07395076
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to better understand why some patients with ARDS (a severe lung condition) get very sick while others recover. Researchers will collect blood and lung fluid from 50 ICU patients to study their immune cells and inflammation patterns. The goal is to identify different patient types so that future treatments can be more personalized and effective.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Lariboisière
RECRUITINGParis, 75010, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune clues may unlock better ECMO care for lung failure patients
- New study aims to Fine-Tune ventilator strategies for ARDS patients
- Can the right dose and timing of steroids save more lives in ARDS?
- New inflatable cushion could revolutionize ICU patient repositioning
- Tailored breathing support may reduce lung injury in ECMO patients
- ARDS ventilator tool faces reliability test